Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/1998
11/24/1998US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component
11/24/1998US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins
11/24/1998US5840580 Population of human cells that lacks mature progenitor cells of the erythroid, lymphoid, and myeloid lineages and is enriched for hematopoietic stem cells
11/24/1998US5840576 Methods and compositions of growth control for cells encapsulated within bioartificial organs
11/24/1998US5840569 Human GTP-binding proteins
11/24/1998US5840568 Screening for hodgkin's disease using a nucleic acid molecule which encodes a hodgkin's disease specific antigen
11/24/1998US5840544 DNA encoding rantes homolog from prostate
11/24/1998US5840540 Sequence determination and expression of familial alzheimer's disease membrane protein
11/24/1998US5840538 Lgt
11/24/1998US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs
11/24/1998US5840529 Mammalian pro-hormone convertase
11/24/1998US5840495 Methods for diagnosis of conditions associated with elevated levels of telomerase activity
11/24/1998US5840493 Diagnosis of late onset diabetes by detection of mutations in adenosine triphosphate synthase or transfer rna (lys) genes in a biological sample; labelled nucleotide sequences as detectors; accuracy
11/24/1998US5840491 DNA sequence encoding the Machado-Joseph disease gene and uses thereof
11/23/1998CA2232810A1 Novel compounds
11/23/1998CA2232809A1 Novel compounds
11/23/1998CA2232808A1 Novel compounds
11/23/1998CA2232807A1 Novel compounds
11/23/1998CA2230996A1 Novel compounds
11/23/1998CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639)
11/23/1998CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/22/1998CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/21/1998CA2232811A1 Novel def1
11/21/1998CA2229436A1 A human gene similar to a secreted murine protein sdf5
11/21/1998CA2224473A1 A novel human gene similar to a secreted murine protein sdf5
11/19/1998WO1998051825A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998WO1998051810A1 Lentivirus-based gene transfer vectors
11/19/1998WO1998051808A1 Methods for producing retroviral vectors with an altered tropism
11/19/1998WO1998051807A1 Episomal expression cassettes for gene therapy
11/19/1998WO1998051798A1 Hgf polypeptides and their use in therapy
11/19/1998WO1998051792A1 Fac molecules and uses thereof
11/19/1998WO1998051790A1 A novel nucleic acid molecule
11/19/1998WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
11/19/1998WO1998051708A1 A method for the improvement of neuronal regeneration
11/19/1998WO1998051351A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998WO1998051341A1 ANTIGEN-mPEG CONJUGATES SUPPRESS HUMORAL AND CELL MEDIATED IMMUNE RESPONSES
11/19/1998WO1998051340A1 Fas ligand expressing antigen presenting cells for tolerance induction
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051285A2 Cationic amphiphile formulations
11/19/1998WO1998051279A2 Method of making microencapsulated dna for vaccination and gene therapy
11/19/1998WO1998051278A2 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
11/19/1998WO1998040483A3 28 human secreted proteins
11/19/1998WO1998040058A3 Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
11/19/1998WO1998037089A3 Matrix derived anti-hiv peptides and transdominant proteins
11/19/1998WO1998034640A3 Synthetic hiv gag genes
11/19/1998WO1998033929A3 Use of a polypeptide as cell receptor for adenoviruses
11/19/1998WO1998026062A3 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them
11/19/1998WO1998026061A3 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
11/19/1998CA2290071A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
11/19/1998CA2289953A1 Methods for producing retroviral vectors with an altered tropism
11/19/1998CA2289720A1 Hgf polypeptides and their use in therapy
11/19/1998CA2288328A1 Lentivirus-based gene transfer vectors
11/19/1998CA2287839A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998CA2286875A1 Chemical compounds
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0878547A1 Methods for producing retroviruses with an altered tropism
11/18/1998EP0878546A1 A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878480A1 A method for the improvement of neuronal regeneration
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20
11/18/1998EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto
11/18/1998EP0877803A1 Ob protein receptor and related compositions and methods
11/18/1998EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS
11/18/1998EP0877796A1 Compositions and methods for mediating cell cycle progression
11/18/1998EP0877760A1 Mhc complexes and uses thereof
11/18/1998EP0877758A2 PURIFIED SR-p70 PROTEIN
11/18/1998EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus
11/18/1998EP0877622A1 Method of inactivation of ras subfamily proteins and agents therefor
11/18/1998EP0877555A1 Method of inhibiting immune system destruction of transplanted viable cells
11/18/1998EP0877549A1 Methods and compositions for the reduction of xenotransplantation rejection
11/18/1998EP0690990B1 Parvovirus receptors and methods of use
11/17/1998US5837856 Chirally enriched synthetic phosphonate oligomers
11/17/1998US5837855 Rna substrates, helices for gene expression, cells, dna and genetic engineering
11/17/1998US5837844 CAIP-like gene family
11/17/1998US5837837 Nucleic acids molecules encoding Caspase-8h and Caspase-8i
11/17/1998US5837694 Method for enhancing neurone survival and agents useful for same
11/17/1998US5837693 Intravenous hormone polypeptide delivery by salivary gland expression
11/17/1998US5837692 Inhibition of the mitogenic activity of PDGF by mammalian EGr
11/17/1998US5837682 Angiostatin fragments and method of use
11/17/1998US5837542 Intercellular adhesion molecule-1 (ICAM-1) ribozymes
11/17/1998US5837536 Expression of human multidrug resistance genes and improved selection of cells transduced with such genes
11/17/1998US5837533 Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
11/17/1998US5837532 Herpes simplex cirus type 1 mutant
11/17/1998US5837531 Recombinant adenoviruses for gene therapy in cancers
11/17/1998US5837520 Method of purification of viral vectors
11/17/1998US5837511 Replication of deficient adenoviral gene transfer vector
11/17/1998US5837510 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders
11/17/1998US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998US5837507 Genetic engineering for hematopoietic stem cells
11/17/1998US5837498 Corpuscles of stannius protein, stanniocalcin
11/17/1998US5837492 Chromosome 13-linked breast cancer susceptibility gene
11/17/1998US5837490 Therapeutic, diagnostic, research uses
11/17/1998US5837451 Identifying composition which affect kinase activity
11/17/1998US5837449 Hybridizable oligonucleotides; genetic engineering; diagnosis, detection and treatment of brain disorders such as alzheimer*s disease
11/17/1998US5837443 Genes and colorectal cancer, testing for detection of proteins
11/17/1998US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/17/1998US5837234 Cell cores and encapsulation
11/16/1998CA2205680A1 Clip immunomodulatory peptide
1 ... 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 ... 870